Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges

Area of Science:

• Oncology
• Molecular Diagnostics
• Genetics

Background:

• Circulating tumor DNA (ctDNA) analysis via liquid biopsies is a promising tool for cancer treatment guidance.
• ctDNA presents analytical challenges due to high fragmentation and low concentrations relative to wild-type DNA.
• Detecting single DNA base pair differences in mutant ctDNA is a significant hurdle.

Purpose of the Study:

• To review the current state-of-the-art in ctDNA detection technologies.
• To critically compare existing analytical techniques for ctDNA analysis.
• To identify necessary improvements for advanced ctDNA diagnostic applications.

Main Methods:

• Review of emerging and established ctDNA detection techniques.
• Comparative analysis of analytical capabilities and practical limitations of various methods.
• Examination of current pilot studies and their promising results.

Main Results:

• Several techniques for analyzing ctDNA have emerged with promising pilot study results.
• Existing methods have drawbacks in analytical performance or practical application, limiting widespread clinical use.
• Advanced ctDNA assay characteristics are needed for expanded applications.

Conclusions:

• New ctDNA detection techniques are crucial for overcoming current limitations.
• Improvements are required to enable applications in companion diagnostics, treatment response monitoring, and early cancer detection.
• Further development could significantly benefit cancer patient management and outcomes.